Jee Tae Keun, Yeon Je Young, Kim Keon Ha, Kim Jong-Soo, Jeon Pyoung
Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
Brain Sci. 2024 Aug 22;14(8):847. doi: 10.3390/brainsci14080847.
Flow diversion has significantly improved the management of cerebral aneurysms. Technological advancements and increased clinical experience over the past decade have led to better outcomes and fewer complications. This study provides updated results and examines the factors that influence the success of flow diversion.
We reviewed records of 115 patients with 121 intracranial aneurysms treated from July 2014 to August 2023. All patients had unruptured aneurysms in the anterior and posterior circulation.
Complete aneurysm occlusion was achieved in 72.7% of cases, with a complication rate of 9.1%. Significant predictors of complete occlusion included aneurysm diameter (OR = 0.89, 95% CI 0.82-0.97, = 0.009) and the presence of incorporated branches (OR = 0.22, 95% CI 0.08-0.59, = 0.003). Cox analysis identified neck diameter (HR = 0.92, 95% CI 0.87-0.98, = 0.009) and incorporated branch (HR = 0.40, 95% CI 0.24-0.69, = 0.001) as significant for occlusion. Multivariable analysis identified aneurysm diameter (OR = 1.21, 95% CI 1.09-1.37, = 0.001) as significant for safety outcomes. Improved outcomes were observed in recent treatments, with higher occlusion rates (79.7% vs. 61.7%, = 0.050) and lower complication rates (4.1% vs. 14.9%, = 0.011).
Enhanced technical proficiency, better devices, and refined patient selection have significantly improved the efficacy and safety of flow diversion for cerebral aneurysms. Identifying significant predictors for treatment success and safety outcomes can inform clinical practice, aiding in patient selection.
血流导向术显著改善了脑动脉瘤的治疗效果。过去十年间的技术进步和临床经验的增加带来了更好的治疗结果和更少的并发症。本研究提供了最新结果,并探讨了影响血流导向术成功的因素。
我们回顾了2014年7月至2023年8月期间治疗的115例患有121个颅内动脉瘤患者的记录。所有患者的前后循环动脉瘤均未破裂。
72.7%的病例实现了动脉瘤完全闭塞,并发症发生率为9.1%。完全闭塞的显著预测因素包括动脉瘤直径(OR = 0.89,95% CI 0.82 - 0.97,P = 0.009)和合并分支的存在(OR = 0.22,95% CI 0.08 - 0.59,P = 0.003)。Cox分析确定瘤颈直径(HR = 0.92,95% CI 0.87 - 0.98,P = 0.009)和合并分支(HR = 0.40,95% CI 0.24 - 0.69,P = 0.001)对闭塞有显著意义。多变量分析确定动脉瘤直径(OR = 1.21,95% CI 1.09 - 1.37,P = 0.001)对安全结果有显著意义。近期治疗的结果有所改善,闭塞率更高(79.7%对61.7%,P = 0.050),并发症发生率更低(4.1%对14.9%,P = 0.011)。
技术水平的提高、更好的器械以及更精细的患者选择显著提高了脑动脉瘤血流导向术的疗效和安全性。确定治疗成功和安全结果的显著预测因素可为临床实践提供参考,有助于患者选择。